Literature DB >> 10633214

Animal models of Graves' disease.

M Ludgate1.   

Abstract

Graves' disease (GD) is an autoimmune condition in which goitre and hyperthyroidism are induced by thyroid stimulating antibodies (TSAB) which mimic the action of thyrotrophin (TSH). The target of the autoimmune response is the thyrotrophin receptor (TSHR) and, since its cloning, a number of differing approaches have been adopted in an attempt to develop an animal model of GD. Methods in which synthetic peptides or fragments of the receptor produced in bacteria or insect cells have been injected into animals together with immunological adjuvants have had only limited success in inducing some of the signs and symptoms of GD. Genetic immunisation resulted in thyroiditis in the majority, but TSAB formation in only a minority, of treated inbred mice. Transfer of receptor in vitro primed T cells to syngeneic naive recipients, with priming either using a bacterial fusion protein or genetic immunisation, induced destructive thyroiditis in non-obese diabetic (NOD) mice but lymphocytic thyroiditis in BALBc mice. Furthermore, the orbits of 17/22 of the BALBc animals, but not the NOD animals, with thyroiditis had orbital changes similar to those seen in thyroid eye disease. TSAB and elevated thyroxine levels were induced in AKR/N mice injected with fibroblasts expressing the full length human TSHR and murine major histocompatibility complex (MHC) class II homologous to the recipient mice. No thyroiditis was induced but preliminary results from a different group using the same protocol suggest that receptor autoantibodies and thyroid dysfunction could be transferred using T cells primed in vitro with the receptor and MHC-II expressing cells. The majority of the studies described above have studied inbred mouse strains. In a novel departure, the NMR outbred strain has been treated by genetic immunisation with very promising results, including the induction of increased thyroxine levels in 4/30 female mice, accompanied by TSAB in addition to thyroiditis, and with signs of hyperactivity and orbital pathology. This review discusses the various protocols together with the information regarding the pathogenesis of GD which each has contributed, and concludes with an evaluation of how close we are to mimicking this polygenic, multifactorial disease.

Entities:  

Mesh:

Year:  2000        PMID: 10633214     DOI: 10.1530/eje.0.1420001

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  9 in total

Review 1.  New understanding of the role of cytokines in the pathogenesis of Graves' ophthalmopathy.

Authors:  R A Ajjan; A P Weetman
Journal:  J Endocrinol Invest       Date:  2004-03       Impact factor: 4.256

2.  News and views: at long last, an animal model of Graves' orbitopathy.

Authors:  Rebecca S Bahn
Journal:  Endocrinology       Date:  2013-09       Impact factor: 4.736

Review 3.  The thyroid, the eyes and the gut: a possible connection.

Authors:  D Covelli; M Ludgate
Journal:  J Endocrinol Invest       Date:  2017-01-07       Impact factor: 4.256

4.  Induction of hyperthyroidism in mice by intradermal immunization with DNA encoding the thyrotropin receptor.

Authors:  K Barrett; E Liakata; P V Rao; P F Watson; A P Weetman; P Lymberi; J P Banga; G Carayanniotis
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

Review 5.  Novel insights on thyroid-stimulating hormone receptor signal transduction.

Authors:  Gunnar Kleinau; Susanne Neumann; Annette Grüters; Heiko Krude; Heike Biebermann
Journal:  Endocr Rev       Date:  2013-05-03       Impact factor: 19.871

6.  An improved method for the establishment of a model of Graves' disease in BALB/c mice.

Authors:  Wei Zheng; Renfei Wang; Jian Tan; Ning Li; Zhaowei Meng
Journal:  Mol Med Rep       Date:  2017-02-08       Impact factor: 2.952

7.  Gut microbiota in experimental murine model of Graves' orbitopathy established in different environments may modulate clinical presentation of disease.

Authors:  Giulia Masetti; Sajad Moshkelgosha; Hedda-Luise Köhling; Danila Covelli; Jasvinder Paul Banga; Utta Berchner-Pfannschmidt; Mareike Horstmann; Salvador Diaz-Cano; Gina-Eva Goertz; Sue Plummer; Anja Eckstein; Marian Ludgate; Filippo Biscarini; Julian Roberto Marchesi
Journal:  Microbiome       Date:  2018-05-25       Impact factor: 14.650

Review 8.  New insights into the pathogenesis and nonsurgical management of Graves orbitopathy.

Authors:  Peter N Taylor; Lei Zhang; George J Kahaly; Marian Ludgate; Richard W J Lee; Ilaria Muller; Daniel G Ezra; Colin M Dayan
Journal:  Nat Rev Endocrinol       Date:  2019-12-30       Impact factor: 43.330

Review 9.  The Molecular Function and Clinical Role of Thyroid Stimulating Hormone Receptor in Cancer Cells.

Authors:  Yu-De Chu; Chau-Ting Yeh
Journal:  Cells       Date:  2020-07-20       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.